Page last updated: 2024-09-04

jte 522 and Body Weight

jte 522 has been researched along with Body Weight in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang-De, J; Damdinsuren, B; Dono, K; Kobayashi, S; Kondo, M; Matsuura, N; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Sekimoto, M; Sugita, Y; Umeshita, K; Wakasa, K; Yamamoto, H1
Ding, Y; Hong, T; Imamura, M; Kaganoi, J; Kawabe, A; Komoto, I; Li, Z; Maeda, M; Sato, F; Shimada, Y1

Other Studies

2 other study(ies) available for jte 522 and Body Weight

ArticleYear
JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
    Gastroenterology, 2003, Volume: 125, Issue:2

    Topics: Actins; Animals; Benzenesulfonates; Body Weight; Choline Deficiency; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA Damage; Genes, myc; Isoenzymes; Liver; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Male; Oxazoles; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar

2003
Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor.
    Carcinogenesis, 2001, Volume: 22, Issue:4

    Topics: Animals; Benzenesulfonates; Body Weight; Carcinogens; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dimethylnitrosamine; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Esophagus; Isoenzymes; Male; Oxazoles; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction

2001